Abstract
Insomnia, sleep apnea, restless leg syndrome, bruxism, narcolepsy and
sleepwalking are all serious sleep disorders that possess negative-and
sometimes fatal-health consequences. Often undiagnosed and thus not treated,
sleep disorders can not only take a toll on personal health but can also
adverse effects on personal relationships and reduce worker productivity. In
examining the troubling increase in a variety of sleep disorders, this TriMark
Publications report will analyze the causes and available treatments for sleep
disorder sufferers. This is a particularly interesting time in the evolution
of the sleep disorders market because the blockbuster drugs that have
dominated this space are coming off patent protection. There has been a strong
push on the part of the major pharmaceutical companies to develop or acquire
replacement sources of revenue. In order to put sleep disorders in a proper
context, the study begins with an examination of key characteristics of the
overall sleep disorders market. The types of disorders, causes of insomnias,
parasomnias and their treatments are analyzed, with the additional review of
treatments including pharmaceuticals, devices (continuous positive airway
pressure or CPAP machines) and others (nutraceuticals, etc.). The report goes
on to describe the primary product offerings of the major companies in this
market space including major classes of prescription and over-the-counter
(OTC) pharmaceuticals. Finally, a review of companies developing treatments
for insomnia, sleep apnea, restless leg syndrome, bruxism, narcolepsy and
sleepwalking are examined.
Methodology
The author of this report is an MD with three decades of experience as a medical products industry analyst. He has
held many senior level positions in hospitals, healthcare and life sciences organizations and companies. The editor
of the report has a PhD in biophysics and has worked as a research assistant professor at the University of Missouri.
Company-specific information is obtained mainly from industry trade publications, academic journals, news and
research articles, press releases and corporate websites, as well as annual reports for publicly-held firms.
Additionally, sources of information include the non-governmental organizations (NGOs) such as the World Health
Organization (WHO) and governmental entities like the U.S. Department of Health and Human Services (HHS) and
U.S. federal agencies such as National Institutes of Health (NIH), Food and Drug Administration (FDA) and the
Centers of Disease Control and Prevention (CDC). Where possible and practicable, the most recent data available
have been used.
Some of the statistical information was taken from Biotechnology Associates' databases and from TriMark' s private
data stores. The information in this study was obtained from sources that we believe to be reliable, but we do not
guarantee the accuracy, adequacy or completeness of any information or omission or for the results obtained by the
use of such information. Key information from the business literature was used as a basis to conduct dialogue with
and obtain expert opinion from market professionals regarding commercial potential and market sizes. Senior
managers from major company players were interviewed for part of the information in this report.
Primary Sources
TriMark collects information from hundreds of Database Tables and many comprehensive multi-client research
projects, and Sector Snapshots that we publish annually. We extract relevant data and analytics from TriMark' s
research as part of this data collection.
Secondary Sources
TriMark uses research publications, journals, magazines, newspapers, newsletters, industry reports, investment
research reports, trade and industry association reports, government-affiliated trade releases and other published
information as part of its secondary research materials. The information is then analyzed and translated by the
Industry Research Group into a TriMark study. The Editorial Group reviews the complete package with product and
market forecasts, critical industry trends, threats and opportunities, competitive strategies and market share
determinations.
| 
View Cart
